Early Access
Experts in Compassionate Use
Early Access Care specializes in Expanded Access (USA) and Compassionate Use (outside of USA)
Our goal is to Make Access More AccessibleTM to patients and their physicians through working for client biopharmaceutical companies.
We offer comprehensive services to manage requests globally, enabling biopharmaceutical company resources to focus on drug development.
Our Services are customized to meet the needs of biopharmaceutical company clients, including:
- Design of Expanded Access programs and Policies
- End-to-end operational management
- Protocol development
- Early Access SystemTM technology eTool
- Single Point of Contact for all physician requests
USA | Early Access Care | Europe | Early Access Care | |
Individual Patient Pre-Approval Use |
Expanded Access (Single Patient IND) |
Named Patient CUP | ||
Multiple Patient Pre-Approval Use |
Expanded Access Protocols (EAP) |
Cohort Protocols CUP |
For more information on individual and multi-patient Expanded Access and Compassionate Use:
- Expanded Access for individual patients (EA or CUP)
- Multi-Patient Expanded Access Protocols (EAPs, Cohorts)
- Post-Trial Access
For information on the technology-enabled Early Access SystemTM